Upstream Bio, Inc. (UPB): Narxning prognoz qilingan daromadga nisbati
Upstream Bio Inc (UPB) dermatit va astmaga qarshi kurashish uchun ilg'or TSLP antitanachalarini ishlab chiqmoqda. Kompaniyaning kutilayotgan P/S koeffitsiyenti grafigi baholash dinamikasini aks ettiradi, bunda ushbu ko'rsatkich hozirda 54.40 darajasida. Firma hozirda o'zining IPOdan keyingi kapitalini qimmatga tushadigan R&D tadqiqotlariga yo'naltirmoqda; biroq, savdoning yo'qligi va qarzga tayanish klinik sinovlarning potentsial muvaffaqiyatsizligi holatida jiddiy xavflarni yuzaga keltiradi.
Upstream Pharma (UPB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Upstream Bio Inc|UPB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Upstream Bio Inc|UPB - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Upstream Pharma|UPB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Upstream Bio|Tezkor likvidlik ko‘rsatkichi upstreambio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
UPB - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Upstream Bio Inc|UPB - Narxning foydaga nisbati|Forvard P/E multiplikatori Upstream Bio Corp|UPB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Upstream Pharma|UPB - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Upstream Bio|UPB - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi upstreambio.com|UPB - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Upstream Bio Inc
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Upstream Bio UPB
Upstream Bio Inc (UPB) qiymati verekimabning klinik muvaffaqiyati va FDA tasdig'i bilan belgilanadi. Taxminiy forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan kelajakdagi savdo aylanmasi bilan solishtirib, potentsial o'sish uchun premiumni o'lchaydi. Ushbu grafik R&D xarajatlarining rentabelligiga nisbatan bozor optimizmi darajasini aks ettiradi. Multiplikatorning pasayishi baholash barqarorligini tasdiqlaydi, uning o'sishi esa har qanday operatsion uzilishlar yuzaga kelgan taqdirda xatarlarni oshiradi.
Upstream Bio Inc raqobatchilari
argenx - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori BioNTech Inc. BNTX|ABVX - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|IMVT - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori KNSA|GRFS (Grifols SA) - Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|CLDX (Celldex Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com (BCRX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|DNTH - Forvard P/S multiplikatori|Pharvaris Corp (PHVS) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori AbCellera Corp|Forvard narx/daromad multiplikatori TRML|PGEN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PHAR|Narxning prognoz qilingan daromadga nisbati NKTR (Nektar Therapeutics Inc)|Forvard P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Immunome Bio (IMNM)|GOSS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati kalvista.com|SEPN (Septerna) - Forvard narx/daromad multiplikatori|Pieris Pharma - Sotuvga nisbatan forvard narx|SVRA (Savara Corp) - Forvard P/S multiplikatori|Rigel Corp (RIGL) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati AnaptysBio, Inc. (ANAB)|astriatx.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori ENGN (enGene)|RAPT - Forvard narx/daromad multiplikatori|JBIO: Forvard narx/daromad multiplikatori|ACRS - Forvard P/S multiplikatori|Kyverna Therapeutics (KYTX) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TLSA (tizianalifesciences.com)|CABA (Cabaletta Bio) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati VTYX|Narxning prognoz qilingan daromadga nisbati Theratechnologies Inc (THTX)|AVTX: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ELDN (Eledon Pharmaceuticals)|Sotuvga nisbatan forvard narx AGEN|Climb Bio - Forvard P/S multiplikatori|ZURA - Forvard P/S multiplikatori|aTyr (ATYR) - Narxning prognoz qilingan daromadga nisbati|Adagene Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati ImageneBio|Forvard narx/daromad multiplikatori Shattuck Therapeutics (STTK)|Forvard P/S multiplikatori EQ|Forvard P/S multiplikatori connectbiopharm.com (CNTB)|Immunic - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ATRA|InflaRx GmbH - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati x4pharma.com XFOR|adicetbio.com (ACET) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Celularity|Narxning prognoz qilingan daromadga nisbati INmune Bio Corp|Forvard narx/daromad multiplikatori Barinthus Biotherapeutics Corp (BRNS)|Forvard narx/daromad multiplikatori KZR (Kezar Life Sciences)|Forvard P/S multiplikatori sabbiotherapeutics.com (SABS)|Narxning prognoz qilingan daromadga nisbati Akari Therapeutics Plc AKTX|ENLV: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Q32 Bio Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Forvard narx/daromad multiplikatori|ibioinc.com (IBIO) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati hcwbiologics.com|Aptevo Therapeutics Inc. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati AIM (AIM ImmunoTech, Inc.)|ADTX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx GRI (GRI Bio Inc)|XRTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vyome Therapeutics (HIND)|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Forvard P/S multiplikatori indaptusrx.com|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|Forvard narx/daromad multiplikatori calcimedica.com CALI|Affimed N.V. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ALLK|HOOKIPA - Forvard P/S multiplikatori|IGMS: Narxning prognoz qilingan daromadga nisbati|ITOS: Forvard P/S multiplikatori|OCEA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Bozor kapitallashuvining kelajakdagi daromadga nisbati Third Harmonic Bio Inc THRD
